REACTIVE SURFACE ON A POLYMERIC SUBSTRATE

• US 20090081797A1
• Filed: 08/29/2008
• Published: 03/26/2009
• Est. Priority Date: 08/31/2007
• Status: Abandoned Application

• Current Assignee: Corning Incorporated
• Original Assignee: Corning Incorporated
• Inventors: FADEEV, ANDREI G, Weber, David Michael, Pal, Santona
• Application Number:
  US12/201,029
• Publication Number:
  US 20090081797A1
• Time in Patent Office: Days
• US Class Current: 436/86
• CPC Class Codes: C08J 2365/00 Characterised by the use of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain C08J2307/00 - C08J2357/00, C08J2361/00 take precedence; Derivatives of such polymers
• CPC Class Codes: C08J 7/123 Treatment by wave energy or particle radiation C08J7/18 takes precedence

Abstract

Plasma treated cyclic polyolefin copolymer surfaces having enhanced binding density for binding biologically active agents and cells are provided. These plasma treated cyclic polyolefin copolymer surfaces may be further enhanced for binding biologically active agents or cells by the application of conjugates. Methods of making and characterizing treated polymer surfaces are also provided.

Claims

1. A method for making a polymer substrate having a working surface upon which biologically active compounds can bind comprising:

providing a cyclic polyolefin copolymer;

treating the cyclic polyolefin copolymer with plasma to provide functional groups on a surface of the polymer substrate;

exposing the plasma-treated copolymer to a conjugate so that the functional groups on the surface of the polymer substrate form covalent bonds with the conjugate;

exposing the polymer surface covalently bound to the conjugate to a biologically active compound so that the biologically active compound is immobilized on the polymer surface.

2. The method of claim 1 wherein the conjugate comprises 1 ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) or a combination of EDC and N-hydroxysuccinimide (NHS).

3. The method of claim 1 wherein the biologically active compound is selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccarides, glycosaminoglycans, proteoglycans, extracellular matrix molecules, cell adhesion molecules, or combinations or fragments thereof.

4. The method of claim 3 wherein the biologically active compound is a peptide.

5. The method of claim 1 wherein the cyclic polyolefin copolymer is treated with microwave plasma.

6. The method of claim 4 wherein the polymer substrate has a peptide binding density greater than 0.5 pmol/mm².

7. The method of claim 4 wherein the polymer substrate has a peptide binding density greater than 1.5 pmol/mm².

8. The method of claim 1 wherein the polymer substrate provides at least a portion of a flask, a dish, a flat plate, a sheet, a well plate, a bottle, a roller bottle, a container, a pipette, a pipette tip, a tube, a bead, a medical device, a filter device, a membrane or a slide.

9. A polymer substrate made by the method of claim 1.

10. A method for making a polymer substrate having a working surface upon which cells can bind comprising:

providing a cyclic polyolefin copolymer;

treating the cyclic polyolefin copolymer with plasma to provide functional groups on a surface of the polymer substrate;

exposing the polymer surface to a conjugate so that the functional groups on the surface of the polymer substrate form covalent bonds with the conjugate;

exposing the polymer surface with covalently bound conjugate to a cell-binding peptide so that the cell binding peptide becomes immobilized on the polymer surface.

11. The method of claim 10 wherein the conjugate comprises 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) or a combination of EDC and N-hydroxysuccinimide (NHS).

12. The method of claim 10 wherein the cell binding peptide comprises KGGNGEPRGDTYRAY (SEQ ID NO 3), NGEPRGDTYRAY (SEQ ID NO 4), KGGPQVTRGDVFTMP (SEQ ID NO 5), or a combination of these.

13. The method of claim 10 wherein the cell-binding peptide is immobilized on the polymer surface via a linker.

14. The method of claim 13 wherein the linker comprises PEG or PEO.

15. The method of claim 10 wherein the cyclic polyolefin copolymer is treated with microwave plasma.

16. The method of claim 10 wherein the polymer substrate provides at least a portion of a flask, a dish, a flat plate, a sheet, a well plate, a bottle, a roller bottle, a container, a pipette, a pipette tip, a tube, a bead, a medical device, a filter device, a membrane or a slide.

17. A method for assessing the number of accessible functional groups on the surface of a polymer available for binding comprising;

providing a plasma-treated cyclic polyolefin copolymer surface having a number of functional groups on its surface to be determined;

exposing the plasma-treated cyclic polyolefin copolymer surface to 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS);

exposing the plasma-treated cyclic polyolefin copolymer surface to labeled biological agent or a mixture or labeled and unlabeled biological agents so that biological agent is immobilized to the surface, and;

determining the amount of label indirectly bound to the surface.

18. The method of claim 17 wherein the biological agent is a labeled polypeptide.

19. A polymer substrate having a working surface upon which cells can bind comprising a cyclic polyolefin copolymer substrate having plasma-treatment-induced functional groups conjugated to cell-binding peptides.

20. The polymeric substrate of claim 19 wherein the cell binding peptide comprises KGGNGEPRGDTYRAY (SEQ ID NO 3), NGEPRGDTYRAY (SEQ ID NO 4), KGGPQVTRGDVFTMP (SEQ ID NO 5), or a combination of these.

21. A method for assigning a rating to a surface comprising:

providing a treated polymer surface having a number of functional groups on its surface to be determined;

exposing the polymer surface to conjugate so that the functional groups on the surface of the polymer form covalent bonds with the conjugate;

exposing the polymer surface covalently bound to the conjugate to labeled biological agent or a mixture or labeled and unlabeled biological agents so that the labeled biological agent becomes immobilized to the polymer surface;

determining the amount of label immobilized to the polymer surface;

assigning a rating to the polymer surface based on the amount of label immobilized to the surface.